These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21897871)

  • 1. Expression of APOBEC3G/3F and G-to-A hypermutation levels in HIV-1-infected children with different profiles of disease progression.
    Amoêdo ND; Afonso AO; Cunha SM; Oliveira RH; Machado ES; Soares MA
    PLoS One; 2011; 6(8):e24118. PubMed ID: 21897871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication.
    Krisko JF; Begum N; Baker CE; Foster JL; Garcia JV
    J Virol; 2016 May; 90(9):4681-4695. PubMed ID: 26912618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
    Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOBEC3G expression and hypermutation are inversely associated with human immunodeficiency virus type 1 (HIV-1) burden in vivo.
    Kourteva Y; De Pasquale M; Allos T; McMunn C; D'Aquila RT
    Virology; 2012 Aug; 430(1):1-9. PubMed ID: 22579353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stably expressed APOBEC3F has negligible antiviral activity.
    Miyagi E; Brown CR; Opi S; Khan M; Goila-Gaur R; Kao S; Walker RC; Hirsch V; Strebel K
    J Virol; 2010 Nov; 84(21):11067-75. PubMed ID: 20702622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms.
    Mbisa JL; Bu W; Pathak VK
    J Virol; 2010 May; 84(10):5250-9. PubMed ID: 20219927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets.
    Koning FA; Newman EN; Kim EY; Kunstman KJ; Wolinsky SM; Malim MH
    J Virol; 2009 Sep; 83(18):9474-85. PubMed ID: 19587057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection.
    Pion M; Granelli-Piperno A; Mangeat B; Stalder R; Correa R; Steinman RM; Piguet V
    J Exp Med; 2006 Dec; 203(13):2887-93. PubMed ID: 17145955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positioning of APOBEC3G/F mutational hotspots in the human immunodeficiency virus genome favors reduced recognition by CD8+ T cells.
    Monajemi M; Woodworth CF; Zipperlen K; Gallant M; Grant MD; Larijani M
    PLoS One; 2014; 9(4):e93428. PubMed ID: 24722422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.
    Tian C; Yu X; Zhang W; Wang T; Xu R; Yu XF
    J Virol; 2006 Mar; 80(6):3112-5. PubMed ID: 16501124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term restriction by APOBEC3F selects human immunodeficiency virus type 1 variants with restored Vif function.
    Albin JS; Haché G; Hultquist JF; Brown WL; Harris RS
    J Virol; 2010 Oct; 84(19):10209-19. PubMed ID: 20686027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication.
    Han Y; Wang X; Dang Y; Zheng YH
    PLoS Pathog; 2008 Jul; 4(7):e1000095. PubMed ID: 18604271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Status of APOBEC3G/F in cells and progeny virions modulated by Vif determines HIV-1 infectivity.
    Yamashita T; Nomaguchi M; Miyake A; Uchiyama T; Adachi A
    Microbes Infect; 2010 Feb; 12(2):166-71. PubMed ID: 19944180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signals in APOBEC3F N-terminal and C-terminal deaminase domains each contribute to encapsidation in HIV-1 virions and are both required for HIV-1 restriction.
    Song C; Sutton L; Johnson ME; D'Aquila RT; Donahue JP
    J Biol Chem; 2012 May; 287(20):16965-74. PubMed ID: 22451677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOBEC3G restricts HIV-1 to a greater extent than APOBEC3F and APOBEC3DE in human primary CD4+ T cells and macrophages.
    Chaipan C; Smith JL; Hu WS; Pathak VK
    J Virol; 2013 Jan; 87(1):444-53. PubMed ID: 23097438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of APOBEC3 variation in a population of HIV-1 infected individuals in northern South Africa.
    Matume ND; Tebit DM; Gray LR; Turner SD; Rekosh D; Bessong PO; Hammarskjöld ML
    BMC Med Genet; 2019 Jan; 20(1):21. PubMed ID: 30660178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity.
    Dang Y; Wang X; York IA; Zheng YH
    J Virol; 2010 Sep; 84(17):8561-70. PubMed ID: 20592083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Disassociation of A3G-Related HIV-1 cDNA G-to-A Hypermutation to Viral Infectivity.
    Martin J; Chen X; Jia X; Shao Q; Liu B
    Viruses; 2024 May; 16(5):. PubMed ID: 38793610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.
    Russell RA; Pathak VK
    J Virol; 2007 Aug; 81(15):8201-10. PubMed ID: 17522216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif.
    Russell RA; Smith J; Barr R; Bhattacharyya D; Pathak VK
    J Virol; 2009 Feb; 83(4):1992-2003. PubMed ID: 19036809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.